naltrexone and Acute Relapsing Multiple Sclerosis

naltrexone has been researched along with Acute Relapsing Multiple Sclerosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mihalova, T; Salam, S; Siripurapu, R	1
Kashipazha, D; Majdinasab, N; Moghtaderi, A; Shalbafan, B; Sharafaddinzadeh, N	1

Trials

1 trial(s) available for naltrexone and Acute Relapsing Multiple Sclerosis

Article	Year
The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial. Multiple sclerosis (Houndmills, Basingstoke, England), 2010, Volume: 16, Issue:8 Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Naltrexone; Narcotic Antagonists; Quality of Life; Surveys and Questionnaires; Young Adult	2010

Article

Year

The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.

Multiple sclerosis (Houndmills, Basingstoke, England), 2010, Volume: 16, Issue:8

Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Naltrexone; Narcotic Antagonists; Quality of Life; Surveys and Questionnaires; Young Adult

2010

Other Studies

1 other study(ies) available for naltrexone and Acute Relapsing Multiple Sclerosis

Article	Year
Severe tumefactive rebound of multiple sclerosis following fingolimod cessation. BMJ case reports, 2016, Jun-03, Volume: 2016 Topics: Adult; Brain; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Multiple Sclerosis, Relapsing-Remitting; Naltrexone; Narcotic Antagonists; Recurrence; Withholding Treatment	2016